Redefining MTM in the Post-health Reform Era
The healthcare industry has hit a crossroads that requires a strategic choice regarding the most effective allocation and use of clinical pharmacy resources on the path to performance improvement. As value-based care models drive the need for greater collaboration across clinical settings, the critical role of pharmacy expertise is heightened to accommodate a greater focus on ensuring medication effectiveness and minimizing potential for medication-related harm — a national crisis that has become the focal point of the risk-bearing regulatory landscape.
You may also like:
According to a recent Centers for Disease Control (CDC) report, 63% of accidental deaths in the U.S. are attributed to some form of opioid use or misuse. Mounting concern over the national crisis of opioid abuse and overutilizatio...
Two recent studies took a closer look at the question of whether antibiotics prevent postoperative complications after third molar surgery. Both found that there are fewer postoperative complications after using antibiotics.
Heads up! Risk Evaluation and Mitigation Strategies, or REMS, have been referenced in a number of recent industry discussions and could present significant challenges to the practice and business of pharmacy over the next several ...
Stay in the Know
Sign up to start receiving notifications via email of our upcoming webinars!